DEGENERATIVE DISC DISEASE

Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease.

What’s important here?

A strong safety profile was demonstrated in the 12 month follow up period with no incidences of infection or other severe adverse events.
Patients demonstrated statistically significant improvements in several parameters including flexion, pain ratings, VAS, PPI, and short form questionnaires. In addition, both ODI and BDI data was trending positive and a majority of patients reported improvements in their Dallas Pain Questionnaire scores. Overall, patients were pleased with the treatment results.

Patients demonstrate a statistically significant improvement in range of motion or flexion.

Patients demonstrate a statistically significant improvement in pain ratings.

Patients demonstrate a statistically significant improvement in visual analog scale and present pain index.